OmniAb Investor Conference Presentation Deck

Illustrative Antibody Deal Structure Profile A Year 0 Collaboration/ Access Fees: ~$1M - $2M 5 10 Clinical & Regulatory Milestones: ~$10M - $20M 15 20 Royalties: ~Low Single Digits Potential IP Extension 25 Year 0 Collaboration/ Access Fees: ~$100k $500k Notes: Deal Economics have evolved over time. Unique deal structures may also be used (e.g., equity stakes, risk-sharing, buy-in options, etc.). Not representative of Icagen ion channel technology deal structures. Profile B 5 10 Clinical & Regulatory Milestones: ~$5M - $15M 15 20 Royalties: ~Mid Single Digits Potential IP Extension 25 28 OmniAb

View entire presentation